5 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 125 points (-0.8%) at 16,333 as of Tuesday, Jan. 21, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,733 issues advancing vs. 1,234 declining with 157 unchanged.

The Health Services industry currently is unchanged today versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include Community Health Systems ( CYH), down 3.9%, Mindray Medical International Limited ADR r ( MR), down 3.4%, Universal Health Services ( UHS), down 2.7% and Baxter International ( BAX), down 0.5%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. Tenet Healthcare ( THC) is one of the companies pushing the Health Services industry lower today. As of noon trading, Tenet Healthcare is down $1.74 (-3.7%) to $45.50 on average volume. Thus far, 1.2 million shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $45.20-$47.48 after having opened the day at $47.30 as compared to the previous trading day's close of $47.24.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $4.7 billion and is part of the health care sector. Shares are up 12.2% year-to-date as of the close of trading on Friday. Currently there are 7 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share and revenue growth. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Tenet Healthcare Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

4. As of noon trading, Agilent Technologies ( A) is down $0.52 (-0.9%) to $60.19 on average volume. Thus far, 970,261 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 2.2 million shares. The stock has ranged in price between $60.07-$60.88 after having opened the day at $60.69 as compared to the previous trading day's close of $60.71.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $20.1 billion and is part of the health care sector. The company has a P/E ratio of 28.9, above the S&P 500 P/E ratio of 17.7. Shares are up 6.2% year-to-date as of the close of trading on Friday. Currently there are 11 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, reasonable valuation levels, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Agilent Technologies Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

3. As of noon trading, HCA Holdings ( HCA) is down $1.67 (-3.2%) to $49.74 on average volume. Thus far, 1.4 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.1 million shares. The stock has ranged in price between $49.55-$51.72 after having opened the day at $51.72 as compared to the previous trading day's close of $51.41.

HCA Holdings, Inc., through its subsidiaries, provides health care services. HCA Holdings has a market cap of $23.0 billion and is part of the health care sector. The company has a P/E ratio of 16.5, below the S&P 500 P/E ratio of 17.7. Shares are up 7.8% year-to-date as of the close of trading on Friday. Currently there are 15 analysts that rate HCA Holdings a buy, no analysts rate it a sell, and 2 rate it a hold.

TheStreet Ratings rates HCA Holdings as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share and poor profit margins. Get the full HCA Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Thermo Fisher Scientific ( TMO) is down $1.09 (-0.9%) to $114.80 on light volume. Thus far, 587,493 shares of Thermo Fisher Scientific exchanged hands as compared to its average daily volume of 1.6 million shares. The stock has ranged in price between $114.75-$116.50 after having opened the day at $116.50 as compared to the previous trading day's close of $115.89.

Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Thermo Fisher Scientific has a market cap of $41.9 billion and is part of the health care sector. The company has a P/E ratio of 31.9, above the S&P 500 P/E ratio of 17.7. Shares are up 4.1% year-to-date as of the close of trading on Friday. Currently there are 12 analysts that rate Thermo Fisher Scientific a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Thermo Fisher Scientific as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, growth in earnings per share and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Thermo Fisher Scientific Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Medtronic ( MDT) is down $0.43 (-0.7%) to $59.08 on light volume. Thus far, 1.6 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.4 million shares. The stock has ranged in price between $59.04-$59.89 after having opened the day at $59.65 as compared to the previous trading day's close of $59.51.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $59.4 billion and is part of the health care sector. The company has a P/E ratio of 15.9, below the S&P 500 P/E ratio of 17.7. Shares are up 3.7% year-to-date as of the close of trading on Friday. Currently there are 8 analysts that rate Medtronic a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and notable return on equity. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Medtronic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

U.S. Crude Oil Hits Fresh 3-Year Highs as Gasoline Heads to $3 a Gallon

U.S. Crude Oil Hits Fresh 3-Year Highs as Gasoline Heads to $3 a Gallon

Stocks Waver Amid Progress on U.S.-China Trade; Dow Slips

Stocks Waver Amid Progress on U.S.-China Trade; Dow Slips

Jim Cramer: Schlumberger Predicted the Rise in Oil Prices

Jim Cramer: Schlumberger Predicted the Rise in Oil Prices

Jim Cramer on Zillow's New Business: Buying and Selling Homes

Jim Cramer on Zillow's New Business: Buying and Selling Homes

Jim Cramer on the Markets: It's Natural to Have Some Profit Taking

Jim Cramer on the Markets: It's Natural to Have Some Profit Taking